Recent progress in understanding glutaric acidemias.
Glutaric acidemia, which is due to inherited deficiency of glutaryl-CoA dehydrogenase, is characterized clinically by progressive dystonia and dyskinesia in childhood, and pathologically by degeneration of the caudate and putamen. Results using newer imaging techniques (computer tomography and magnetic resonance image scanning) suggest that neurological involvement in this condition begins before birth, and that gliosis of the basal ganglia is a relatively late event. Glutaric acidemia type II is usually due to inherited deficiency of electron transfer flavoprotein (ETF) or ETF:ubiquinone oxidoreductase, but some patients with typical disease may have another, to date undefined, abnormality. There may also be a clinical phenotype of glutaric acidemia type II which, like glutaryl-CoA dehydrogenase deficiency, is characterized by a movement disorder and by degeneration of the basal ganglia.
D002675:Child, Preschool; D044927:Electron-Transferring Flavoproteins; D005260:Female; D005420:Flavoproteins / Q000172:deficiency*; D005977:Glutarates / Q000097:blood*; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000097:blood* / Q000235:genetics / Q000503:physiopathology; D016660:NAD(P)H Dehydrogenase (Quinone); D010088:Oxidoreductases / Q000172:deficiency; D010641:Phenotype; D011808:Quinone Reductases / Q000172:deficiency*
D044927:Electron-Transferring Flavoproteins; D005420:Flavoproteins; D005977:Glutarates; D010088:Oxidoreductases; D016660:NAD(P)H Dehydrogenase (Quinone); D011808:Quinone Reductases; C035736:glutaric acid